chr10-110964362-A-G

Variant summary

Our verdict is Uncertain significance.
+5 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 5 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_StrongO3_Supporting

The NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The gene SHOC2 is a known oncogene (CancerMine: 2 oncogene, 1 driver citations). The gene SHOC2 is a cancer driver gene (CancerMine: 2 oncogene, 1 driver citations). The variant allele was found at a cumulative frequency of 0.00000342 (AC=5) in the gnomAD database across 1,460,838 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000147. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.49). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000605107: Functional characterization of the p.Ser2Gly protein indicates enhanced myristoylation, and aberrant targeting of the SHOC2 to the cell membrane in the absence of growth factor signaling (Cordeddu 2009). PMID:19684605" and additional evidence is available in ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S2T: Uncertain_significance (ClinVar VariationId 2265459, 1 star) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). The variant has been observed in cBioPortal in 3 samples across 2 studies and 3 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

SHOC2
NM_007373.4 missense

Scores

3
8
8

Clinical Significance

Pathogenic reviewed by expert panel P:50O:1

Conservation

PhyloP100: 8.49

Publications

97 publications found
Variant links:
Genes affected
SHOC2 (HGNC:15454): (SHOC2 leucine rich repeat scaffold protein) This gene encodes a protein that consists almost entirely of leucine-rich repeats, a domain implicated in protein-protein interactions. The protein may function as a scaffold linking RAS to downstream signal transducers in the RAS/ERK MAP kinase signaling cascade. Mutations in this gene have been associated with Noonan-like syndrome with loose anagen hair. [provided by RefSeq, May 2010]
SHOC2 Gene-Disease associations (from GenCC):
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome-like disorder with loose anagen hair 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007373.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 5 points.

O1Established oncogenic variant
CGI exact DNA-change oncogenic — Strong (O1); O1 contributing sources (4.0 pts): CGI (Cancer Genome Interpreter)
O3Absent or very rare in population
Very rare in gnomAD (popmax AF <0.01%) — O3 supporting; GnomAD effective popmax AF = 0.000015 — very rare (O3 supporting [+1])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_007373.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

SHOC2 NM_007373.4
MANE Select
HGVSc / HGVSpc.4A>Gp.Ser2Gly
Exon rankExon 2 of 9
missense
Prot: NP_031399.2
SHOC2 NM_001324336.2
HGVSc / HGVSpc.4A>Gp.Ser2Gly
Exon rankExon 2 of 9
missense
Prot: NP_001311265.1UniProt: Q9UQ13-1
SHOC2 NM_001324337.2
HGVSc / HGVSpc.4A>Gp.Ser2Gly
Exon rankExon 3 of 10
missense
Prot: NP_001311266.1UniProt: Q9UQ13-1

Ensembl Transcripts

SHOC2 ENST00000369452.9
TSL:1MANE Select
HGVSc / HGVSpc.4A>Gp.Ser2Gly
Exon rankExon 2 of 9
missense
Prot: ENSP00000358464.5UniProt: Q9UQ13-1
SHOC2 ENST00000685059.1
HGVSc / HGVSpc.4A>Gp.Ser2Gly
Exon rankExon 3 of 10
missense
Prot: ENSP00000510210.1UniProt: Q9UQ13-1
SHOC2 ENST00000688928.1
HGVSc / HGVSpc.4A>Gp.Ser2Gly
Exon rankExon 2 of 9
missense
Prot: ENSP00000509273.1UniProt: Q9UQ13-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.00000657
AC:1
Hom:0
AN:152166
Cov:32
GnomAD4 exome
AF: 0.00000342
AC:5
Hom:0
AN:1460838
Cov:31
GnomAD4 genome
Warning
AF: 0.00000657
AC:1
Hom:0
AN:152166
Cov:32
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00000979
AC:2
Hom:0
AN:204292
Showing 4 sources

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
27
-
-
Noonan syndrome-like disorder with loose anagen hair 1 (28)
11
-
-
not provided (11)
3
-
-
RASopathy (3)
2
-
-
Noonan syndrome (2)
1
-
-
Cardiovascular phenotype (1)
1
-
-
Houge-Janssens syndrome 2 (1)
1
-
-
Noonan syndrome and Noonan-related syndrome (1)
1
-
-
Noonan syndrome-like disorder with loose anagen hair (1)
1
-
-
Pectus excavatum;C4478716:Noonan syndrome-like disorder with loose anagen hair 1 (1)
1
-
-
Polycystic kidney disease 4 (1)
1
-
-
SHOC2-related disorder (1)

Computational Scores

AlphaGenome AVI
Pathogenic21
AlphaMissense
Benign0.11
BayesDel_addAF
Uncertain0.16D
BayesDel_noAF
Uncertain-0.010
CADD
Uncertain25
DANN
Uncertain1.0
DEOGEN2
Benign0.17T
Eigen
Uncertain0.51
Eigen_PC
Uncertain0.58
FATHMM_MKL
Pathogenic0.99D
GPN-Star LLR
N/A-7.4
GPN-Star score
N/A7.4
LIST_S2
Benign0.76T
M_CAP
Benign0.023T
MetaRNN
Pathogenic0.85D
MetaSVM
Benign-0.87T
Mutation Taster
N/A13/87disease causing (ClinVar)
MutationAssessor
Benign1.9M
PhyloP100
Pathogenic8.5
popEVE
Benign-3.3
PrimateAI
Uncertain0.71T
PROVEAN
Benign-0.35N
REVEL
Uncertain0.39
Sift
Pathogenic0.0D
Sift4G
Benign0.60T
Varity_R
N/A0.44
VESM-3B
Benign-4.3
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs267607048;
hg19: chr10-112724120;
COSMIC: COSV54624833;
COSMIC: COSV54624833;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.